Histogen Hair Regrowth Clinical Trial
During the International Society of Hair Restoration Surgeons (ISHRS) Annual Meeting, Histogen Hair Regrowth clinical trial was presented for the first time. The results of the clinical trial were as follows.
“The five-month double-blind, placebo-controlled clinical trial was focused on evaluation of safety in the clinical application of Histogen’s Hair Stimulating Complex (HSC), formerly known as ReGenica. The 24 subject clinical trial was designed to examine the safety and efficacy of a single injection of HSC alone, as well as in combination with three different perturbation methods. Quantitative analysis of clinical macrophotography and subject biopsies were utilized to evaluate treatment safety and efficacy.
84.6% of the patients receiving one injection of Histogen’s serum-free HSC showed an increase in terminal hair 12 weeks post-injection, with a statistically significant (p<0.05) increase in the number of terminal hairs, cumulative hair thickness density and hair thickness mean. Perturbation did not enhance the results seen with HSC. There were no adverse reactions seen in any of the treated 24 patients at baseline, 12 weeks, or the 22 week endpoint.”
Histogen, Inc. is a regenerative medicine company that develop solutions based on the products of newborn fibroblasts grown under embryonic conditions. You can read the rest of the press release here: http://www.prweb.com/releases/Histogen/HairRegrowth/prweb2679084.htm
If you want natural hair regrowth, then check out Provillus reviews. It treats the root causes of baldness. It works towards reducing the effects of Dehyrotestosterone in men and restoring hormonal balance in women.
